Budget impact assessment of Aprokam® compared with unlicensed cefuroxime for prophylaxis of post-cataract surgery endophthalmitis

BACKGROUND: Intracameral cefuroxime is recommended as prophylaxis against postoperative endophthalmitis (POE) following cataract surgery. Aprokam is the only licensed product for prophylaxis of POE, although unlicensed intracameral cefuroxime may be administered using pre-filled syringes (PFS), eith...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Ophthalmol
Autors principals: Purslow, Christine, Davey, Keith, Johnson, Mildred, Pietri, Guilhem, Suri, Gaurav
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2015
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4495806/
https://ncbi.nlm.nih.gov/pubmed/26152124
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12886-015-0056-5
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars